SCHEMBL4289308

SCHEMBL4289308

O=C(ON1C(=O)CC(S(=O)(=O)O)C1=O)c1cccc(N2C(=O)C=CC2=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.40
MGLL Q99685 6/20 0.38
FAAH O00519 3/20 0.38
ATM Q13315 1/20 0.38
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
RECQL P46063 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351152 1.00 GAA (0.41) GAAMAPK1MGLLFAAHATM
SCHEMBL9294612 0.99 GAA (0.40) GAAMAPK1MGLLFAAHATM
SCHEMBL9294605 0.89 GAA (0.39) GAAMAPK1MGLLFAAHATM
SCHEMBL24393466 0.86 ALDH1A1 (0.44) GAAMAPK1MGLLFAAHKMT2A
SCHEMBL21855116 0.84 GAA (0.44) GAAMAPK1MGLLFAAHATM
SCHEMBL12410091 0.83 GAA (0.46) GAAMAPK1MGLLFAAHATM
SCHEMBL15080488 0.81 MAPK1 (0.43) GAAMAPK1MGLLFAAHATM
SCHEMBL21167217 0.81 ALDH1A1 (0.38) KMT2AMEN1CYP1A2MAPTCYP2C9
SCHEMBL15783840 0.80 GAA (0.41) GAAMAPK1MGLLFAAHATM
SCHEMBL13499101 0.80 GAA (0.40) GAAMAPK1MGLLFAAHATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295736-B2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof BAR ILAN UNIVERSITY (IL) 2016-03-29 US claimed
US-20120141380-A1 POLYMER NANOPARTICLES COATED BY MAGNETIC METAL OXIDE AND USES THEREOF HENRY FORD HOSPITAL (US) 2012-06-07 US claimed
US-20090110644-A1 Polymer nanoparticles coated by magnetic metal oxide and uses thereof BAR-ILAN UNIVERSITY 2009-04-30 US claimed
EP-1088315-B1 NUCLEATION AND GROWTH OF MAGNETIC METAL OXIDE NANOPARTICLES AND ITS USE UNIV BAR ILAN (IL) 2003-06-25 EP claimed
JP-2002517085-A 2002-06-11 JP claimed
EP-1088315-A1 NUCLEATION AND GROWTH OF MAGNETIC METAL OXIDE NANOPARTICLES AND ITS USE BAR-ILAN UNIVERSITY (IL) 2001-04-04 EP claimed
WO-1999062079-A1 NUCLEATION AND GROWTH OF MAGNETIC METAL OXIDE NANOPARTICLES AND ITS USE BAR-ILAN UNIVERSITY (IL) 1999-12-02 WO claimed
US-12558297-B2 Consumer product with controlled release, biodegradable core-shell microcapsule compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2026-02-24 US disclosed
CN-113950315-B Consumer product with controlled release biodegradable core-shell microcapsule composition 国际香料和香精公司 2024-08-02 CN disclosed
CN-113993499-B Sustainable core-shell microcapsules prepared with a combination of cross-linking agents 国际香料和香精公司 2024-07-23 CN disclosed
CN-113939192-B Controlled release biodegradable core-shell microcapsule compositions 国际香料和香精公司 2023-08-11 CN disclosed
US-20220226797-A1 SUSTAINABLE CORE-SHELL MICROCAPSULES PREPARED WITH COMBINATIONS OF CROSS-LINKERS INT FLAVORS & FRAGRANCES INC (US) 2022-07-21 US disclosed
US-20220177815-A1 CONTROLLED RELEASE, BIODEGRADABLE CORE-SHELL MICROCAPSULE COMPOSITIONS INT FLAVORS & FRAGRANCES INC (US) 2022-06-09 US disclosed
EP-1088315-A1 NUCLEATION AND GROWTH OF MAGNETIC METAL OXIDE NANOPARTICLES AND ITS USE BAR-ILAN UNIVERSITY (IL) 2001-04-04 EP disclosed
WO-1999062079-A1 NUCLEATION AND GROWTH OF MAGNETIC METAL OXIDE NANOPARTICLES AND ITS USE BAR-ILAN UNIVERSITY (IL) 1999-12-02 WO disclosed
EP-0755941-A2 Polypeptide and process for measuring living body components using the same WAKO PURE CHEMICAL INDUSTRIES LTD (JP) 1997-01-29 EP disclosed
EP-0466565-B1 Kit for the specific determination of Angiotensin II SANOFI SA (FR) 1996-05-22 EP disclosed
US-5132226-A METHOD FOR THE DETERMINATION OF MALEIMIDE GROUPS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1992-07-21 US disclosed
EP-0466565-A1 Kit for the specific determination of Angiotensin II SANOFI (FR) 1992-01-15 EP disclosed
EP-0227351-A2 Immobilized C-peptide antibody, and the preparation and use thereof SHIONOGI & CO., LTD. (JP) 1987-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12558297-B2 Consumer product with controlled release, biodegradable core-shell microcapsule compositions LCT, CUTA, LIPE GAA 38/4885MAPK1 4323/4885MGLL 111/4885
US-20220177815-A1 CONTROLLED RELEASE, BIODEGRADABLE CORE-SHELL MICROCAPSULE COMPOSITIONS LIPA, MLEC, CHMP4B GAA 229/4885MAPK1 4876/4885MGLL 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.